You have 9 free searches left this month | for more free features.

Human Papillomavirus (HPV)

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Women's Values in Managing Human Papillomavirus (HPV)

Not yet recruiting
  • Human Papilloma Virus Infection
  • No intervention
  • (no location specified)
Nov 6, 2023

Head and Neck Carcinoma, Adult Disease Trial in Villejuif (HPVDC injection level dose 1, injection level dose 1, HPVDC

Recruiting
  • Head and Neck Carcinoma
  • Adult Disease
  • HPVDC injection level dose 1
  • +3 more
  • Villejuif, France
    Gustave Roussy
Aug 17, 2023

HPV Associated Cancers Trial in New York, Houston (TGN-S11, Pembrolizumab)

Not yet recruiting
  • HPV Associated Cancers
  • New York, New York
  • +1 more
Apr 25, 2023

Human Papillomavirus (HPV)-Related Malignancies, Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related Malignancies

Completed
  • Human Papillomavirus (HPV)-Related Malignancies
  • Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related Malignancies
  • Basking Ridge, New Jersey
  • +5 more
Dec 14, 2022

Cervical Intraepithelial Neoplasia Grade I/ II/ III (CIN I/II/III), Human Papillomavirus (HPV) Infections, High-risk HPV Trial

Recruiting
  • Cervical Intraepithelial Neoplasia Grade I/ II/ III (CIN I/II/III)
  • +3 more
  • Nonavalent HPV vaccine (9vHPV/Gardasil-9™).
  • L'Hospitalet De Llobregat, Catalunya, Spain
    Gynaecology Unit, Bellvitge University Hospital (HUB)
Jan 24, 2023

Human Papillomavirus-Related Carcinoma Trial in Seattle (Discussion, Educational Activity, Healthcare Activity)

Recruiting
  • Human Papillomavirus-Related Carcinoma
  • Discussion
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Apr 26, 2023

Human Papillomavirus Infection Trial in Nanjing (Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus

Completed
  • Human Papillomavirus Infection
  • Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia Coli)
  • Recombinant nonavalent Human Papillomavirus (Types 6,11,16,18,31,33,45,52,58) Vaccine
  • Nanjing, Jiangsu, China
    CDC, Jiangsu Province
Jan 12, 2023

Warts Trial in Salt Lake City (Human Papillomavirus 9-valent Vaccine, Recombinant, Normal Saline)

Not yet recruiting
  • Warts
  • Human Papillomavirus 9-valent Vaccine, Recombinant
  • Normal Saline
  • Salt Lake City, Utah
  • +1 more
Nov 23, 2022

Human Papilloma Virus Infection Trial in Nanjing (Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus

Completed
  • Human Papilloma Virus Infection
  • Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia Coli)
  • Recombinant Quadrivalent Human Papillomavirus (Types 6,11,16,18) Vaccine (Saccharomyces cerevisiae)
  • Nanjing, Jiangsu, China
    CDC, Jiangsu Province
Jan 12, 2023

Longitudinal HPV Pap in CIN and VAIN

Recruiting
  • Cervical Intraepithelial Neoplasia
  • +3 more
  • HPV test and Pap Smear
  • Taoyuan City, Taiwan
    Chang Gung Medical Foundation
Jun 27, 2023

Human Papillomavirus Infection Trial in Guangzhou, Nanjing, Taiyuan (Recombinant Nonavalent (types 6/11/16/18/31/33/45/52/58)

Active, not recruiting
  • Human Papillomavirus Infection
  • Recombinant Nonavalent (types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia coli)
  • Recombinant Quadrivalent Human Papillomavirus (Types 6,11,16,18) Vaccine (Saccharomyces cerevisiae)(GARDASIL®)
  • Guangzhou, Guangdong, China
  • +2 more
Dec 30, 2022

HPV Trial in Hershey (Evalyn Brush)

Terminated
  • HPV
  • Evalyn Brush
  • Hershey, Pennsylvania
    Jennifer Moss
Nov 17, 2022

Human Papillomavirus Infection Trial in United States (Laboratory Biomarker Analysis, Questionnaire Administration, Recombinant

Active, not recruiting
  • Human Papillomavirus Infection
  • Laboratory Biomarker Analysis
  • +2 more
  • Birmingham, Alabama
  • +5 more
Jan 26, 2023

Human Papillomavirus Infection Trial in Canberra (Human papillomavirus (HPV) Vaccine, Placebo)

Not yet recruiting
  • Human Papillomavirus Infection
  • Human papillomavirus (HPV) Vaccine
  • Placebo
  • Canberra, Australia
    Paratus Clinical Research Canberra
Jan 4, 2023

HPV Trial in Hershey (HPV Self-Sampling Kit (Evalyn Brush))

Terminated
  • HPV
  • HPV Self-Sampling Kit (Evalyn Brush)
  • Hershey, Pennsylvania
    Penn State College of Medicine
Nov 17, 2022

High Grade Intraepithelial Trial (HPV detection test)

Not yet recruiting
  • High Grade Intraepithelial
  • HPV detection test
  • (no location specified)
Jul 7, 2022

Verruca Plantaris Trial in Surrey (Sterile water foot bath, Nitric Oxide)

Not yet recruiting
  • Verruca Plantaris
  • Sterile water foot bath
  • Nitric Oxide
  • Surrey, British Columbia, Canada
    Achilles Foot Health Centre
May 26, 2023

Modeling From Human Papillomavirus (HPV)

Completed
  • GYNAECOLOGICAL INFECTION
    • Paris, France
      Hopital La Pitié Salpêtrire
    Mar 21, 2022

    Human Papillomavirus Infection Trial in Kunming (Recombinant Nonavalent (types 6/11/16/18/31/33/45/52/58) Human Papillomavirus

    Active, not recruiting
    • Human Papillomavirus Infection
    • Recombinant Nonavalent (types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia coli)
    • GARDASIL® 9
    • Kunming, Yunnan, China
      Yunnan Center for Disease Prevention and Control
    Dec 23, 2022

    Using Human Papillomavirus DNA Testing to Detect HPV-Related

    Recruiting
    • Oropharyngeal Cancer
    • +2 more
    • NavDx
    • Basking Ridge, New Jersey
    • +6 more
    Apr 3, 2023

    HPV - Anogenital Human Papilloma Virus Infection, HIV Trial in Brussels (Vaccine)

    Active, not recruiting
    • HPV - Anogenital Human Papilloma Virus Infection
    • HIV Infections
    • Vaccine
    • Brussels, Belgium
      Service de Maladies Infectieuses, CHU Saint-Pierre
    Jul 19, 2022

    Human Papillomavirus Vaccine Trial in Banjul (9-valent human papillomavirus vaccine (Gardasil 9) - 3 doses, 9-valent human

    Active, not recruiting
    • Human Papillomavirus Vaccine
    • 9-valent human papillomavirus vaccine (Gardasil 9) - 3 doses
    • +2 more
    • Banjul, Outside U.S. And Canada, Gambia
      Ed Clarke
    Mar 15, 2022

    Cervical Cancer, Throat Cancer, Oropharynx Cancer Trial in New Brunswick (E7 TCR-T cells)

    Not yet recruiting
    • Cervical Cancer
    • +20 more
    • E7 TCR-T cells
    • New Brunswick, New Jersey
    • +1 more
    Jan 18, 2023

    Lichen Planus Trial in Besançon, Paris, Reims (Human biological samples)

    Completed
    • Lichen Planus
    • Human biological samples
    • Besançon, France
    • +2 more
    Feb 14, 2022

    Vulvar Intraepithelial Neoplasia Grade 2, Vulvar Intraepithelial Neoplasia Grade 3 Trial (VTD-101 ointment)

    Not yet recruiting
    • Vulvar Intraepithelial Neoplasia Grade 2
    • Vulvar Intraepithelial Neoplasia Grade 3
    • VTD-101 ointment
    • (no location specified)
    Feb 3, 2023